FINWIRES · TerminalLIVE
FINWIRES

ResMed Posts Higher Fiscal Q3 Non-GAAP Earnings, Revenue

By

-- ResMed (ASX:RMD) reported Friday fiscal third-quarter non-GAAP earnings of $2.86 per share, up from $2.37 a year earlier.

Analysts polled by FactSet expected earnings of $2.80.

Revenue for the three months ended March 31 was $1.43 billion, compared with $1.29 billion a year earlier. Analysts surveyed by FactSet expected $1.42 billion.

The company expects its fiscal 2026 non-GAAP gross margin to be between 62% and 63%.

The board declared a quarterly dividend of $0.60 per share, up from $0.53 a year earlier, payable June 18 to shareholders on record as of May 14.

Related Articles

Asia

Shanghai International Airport's Q1 Profit Rises 11%

Shanghai International Airport's (SHA:600009) net profit attributable to shareholders in the first quarter rose 11% to 577.8 million yuan from the year-ago attributable profit of almost 519.0 million yuan, according to a Shanghai bourse filing on Thursday.Earnings per share climbed 10% year on year to 0.23 yuan from 0.21 yuan.Operating revenue inched 0.8% higher to 3.20 billion yuan from 3.17 billion yuan in the preceding year.

$SHA:600009
Asia

Shanghai International Airport's 2025 Profit Rises 10%, Revenue Climbs 8%

Shanghai International Airport's (SHA:600009) net profit attributable to shareholders in 2025 rose 9.5% to 2.12 billion yuan from 1.93 billion yuan a year earlier, according to a Shanghai bourse filing on Thursday.Earnings per share climbed 9% year on year to 0.85 yuan from 0.78 yuan.Operating revenue gained 7.9% to 13.35 billion yuan from 12.37 billion yuan in the previous year.

$SHA:600009
Asia

ResMed CFO to Retire

ResMed (ASX:RMD) said that Chief Financial Officer Brett Sandercock plans to retire, effective May 4, according to a Friday statement by the company.Aaron Bloomer will succeed Sandercock, who will remain an adviser to the chief executive through 2027, the company said.Bloomer was CFO of Exact Sciences, which was recently acquired by New York Stock Exchange-listed Abbott.

$ASX:RMD